January 3rd, 2012
Bariatric Surgery Cuts Cardiovascular Deaths and Events
Larry Husten, PHD
Bariatric surgery results in significant reductions in cardiovascular deaths and events, according to a new study from Sweden published in JAMA. But one expert cautions that the results do not mean that obese patients without other weight-related complications should undergo surgery.
Analyzing data from more than 4000 obese patients enrolled in the ongoing Swedish Obese Subjects (SOS) study, Lars Sjöström and colleagues found that bariatric surgery was associated with a reduction in cardiovascular events and deaths after a median follow-up of 14.7 years. (The investigators had previously reported a reduction in total mortality in the surgery group.)
- CV deaths: 28 in the surgery group versus 49 in the control group (HR 0.47, CI 0.29- 0.76, p=0.002)
- MI or stroke: 199 versus 234, (HR 0.67, CI 0.54-0.83, p<0.001)
In a surprising finding, the investigators found no significant association between either weight at baseline or weight loss after surgery and cardiovascular events. The authors speculate this may have been due to the low statistical power of the study to detect an association or, alternatively, that the greatest benefit was derived from the initial modest weight loss caused by the surgery.
Taken with previous reports, the results, write the authors, “demonstrate that there are many benefits to bariatric surgery and that some of these benefits are independent of the degree of the surgically induced weight loss.”
In an accompanying editorial, Edward Livingston writes that “because the expected health benefits do not necessarily exceed the risks of weight loss operations, obese patients without other weight-related complications generally should not undergo bariatric surgery.” He suggests that the NIH convene a new expert panel “to rigorously assess the available evidence and provide updated recommendations for bariatric procedures for the treatment of obesity.”
Categories: Cardiac Surgery, General, Prevention
Tags: bariatric surgery, weight loss
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Improving Global Air-Quality Indices — The WHO’s New Roadmap June 25, 2026Many countries rely on air-quality indices to inform the public and help protect people during short-term increases in air pollution. Their use has important societal and economic implications.
- Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery June 25, 2026In a cluster-randomized trial involving patients having major noncardiac surgery, tranexamic acid reduced the need for red-cell transfusion during hospitalization and was noninferior to placebo for venous thromboembolism within 90 days.
- When Health Costs No Longer Count — Air Pollution and EPA Rulemaking June 25, 2026The EPA has decided to stop considering the monetary value of public health benefits in federal rulemaking related to air pollution. This decision could have profound health consequences.
- TRACTION for Greater Surgical Use of Tranexamic Acid June 25, 2026Every year, many millions of surgical patients worldwide are unnecessarily exposed to a higher-than-necessary risk of blood transfusion because they do not receive a single dose of tranexamic acid just before the surgery. This failing is due not to a lack of high-quality scientific evidence on the overall safety, efficacy,...
- Catheter Ablation for Persistent Atrial Fibrillation June 25, 2026Atrial fibrillation is one of the most common cardiac conditions and is associated with important adverse effects on quality of life, major cardiovascular and neurovascular outcomes, survival, and health care use. Improved outcomes have been seen with pursuit of sinus rhythm,1 and catheter ablation has been more effective...
- Improving Global Air-Quality Indices — The WHO’s New Roadmap June 25, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
